Skip to main content
. Author manuscript; available in PMC: 2014 Mar 3.
Published in final edited form as: Eur J Pharmacol. 2008 Jun 7;590(0):363–368. doi: 10.1016/j.ejphar.2008.06.001

Fig. 2. Effects of PKC inhibitors on agonist-induced contraction in mouse corpus cavernosum.

Fig. 2

Fig. 2

(A) Pre-treatment of Gö6976 did not alter phenylephrine-induced contraction (■: control; ▲: pre-treated with 10 µM of Gö6976). n=6. (B) Pre-treatment of chelerythrine had no significant effect on the contractile responses to phenylephrine. (■: control; ▲: pre-treated with 30 µM of chelerythrine). n=4. (C) Gö6976 had no effect on U4419-induced contraction (■: control; ▲: pre-treated with 10 µM of Gö6976). n=4. (D) Chelerythrine had no effect on the contractions-induced by U44619 (■: control; ▲: pre-treated with 30 µM of chelerythrine). n=4.